Sang Ling Wu, MD, Wei Li, MD, PhD, Alice Wells, MT(ASCP), and Amitava Dasgupta, PhD
|
|
- Whitney Stokes
- 5 years ago
- Views:
Transcription
1 Clinical Chemistry / DIGOXIN-LIKE AND DIGITOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN ELDERLY PEOPLE Digoxin-Like and Digitoxin-Like Immunoreactive Substances in Elderly People Impact on Therapeutic Drug Monitoring of Digoxin and Digitoxin Concentrations Sang Ling Wu, MD, Wei Li, MD, PhD, Alice Wells, MT(ASCP), and Amitava Dasgupta, PhD Key Words: Digoxin-like immunoreactive substances; Digitoxin-like immunoreactive substances; DLIS; DTLIS; Elderly people; Digoxin Abstract We compared digoxin-like (DLIS) and digitoxin-like (DTLIS) immunoreactive substance concentrations for 30 people older than 65 years with those for 25 people younger than 50. None received digoxin or had liver disease, uremia, or volume expansion. We found no DTLIS in any specimen, and only 1 specimen from an elderly person demonstrated a low DLIS concentration. In addition, for 22 non volume expanded patients (8 younger than 50 years and 14 older than 65) receiving digoxin, the fluorescence polarization (FPIA) and the microparticle enzyme (MEIA) immunoassays revealed comparable serum digoxin concentrations, indicating an insufficient DLIS concentration to interfere with digoxin immunoassay results. Therefore, elderly people who are not volume expanded do not have elevated DLIS or DTLIS concentrations. Furthermore, for patients with liver disease or uremia (18 older than 65 years and 20 younger than 50), the DLIS and DTLIS concentrations were elevated. Finally, for 5 patients with liver disease who received digoxin, serum digoxin concentrations were lower by MEIA and higher by FPIA, indicating the patients had elevated DLIS levels that interfered with the assays. Elevated DLIS and DTLIS concentrations are associated with volume expansion and not age. Digoxin-like immunoreactive substances (DLIS) crossreact with antidigoxin antibodies and interfere with the serum digoxin measurement by immunoassays. 1,2 Although the concentration of DLIS in serum samples of healthy people is below the detection limit of a digoxin immunoassay, DLIS concentrations can be elevated substantially in volume expanded conditions, such as uremia, liver disease, essential hypertension, hypertension with water volume expansion, and congestive heart failure. 3-6 DLIS are bound strongly to serum protein, while digoxin is only 25% bound to serum albumin. 7 Interference of DLIS in digoxin measurement by immunoassays has been well documented in the literature. Digoxin has a narrow therapeutic range, and false elevation of serum digoxin concentration due to DLIS is troublesome. 8 Negative interference of DLIS in serum digoxin measurement by the new Abbott nonpretreatment digoxin assay has been reported. 9,10 This is a serious problem because the physician may increase the digoxin dosage based on these falsely lower digoxin levels, resulting in toxic effects of digoxin. Serum from volume-expanded patients also has factors that cross-react with the fluorescence polarization immunoassay (FPIA) of digitoxin. Apparent digitoxin concentrations as high as 21.2 ng/ml (27.8 nmol/l) have been reported in a patient with liver disease but receiving no digitoxin. 11 This is an important cross-reactivity because the therapeutic range of digitoxin is 20.0 to 35.0 ng/ml ( nmol/l). Ebara et al 12 used an enzyme immunoassay for digitoxin and reported a digitoxin equivalent concentration of 15.0 ng/ml (19.7 nmol/l) in cord blood. Another interesting feature is that a serum specimen from a patient may have a measurable concentration of DLIS but no detected concentration of digitoxin-like immunoreactive substances (DTLIS) and vice versa. The correlation between DLIS and DTLIS concentrations is poor Am J Clin Pathol 2001;115: American Society of Clinical Pathologists
2 Clinical Chemistry / ORIGINAL ARTICLE Digoxin is used widely in elderly patients to treat various cardiac disorders. Elderly patients also are sensitive to the toxic effects of digoxin, and their serum digoxin concentrations should be monitored closely. Clinical conditions, such as essential hypertension and renal dysfunction, are more common in elderly people. Such clinical conditions may increase the serum DLIS and DTLIS concentrations. DLIS interference in serum digoxin measurement may be an important factor in elderly patients and should be considered to avoid the toxic effects of digoxin. Digitoxin also is used to treat cardiovascular disease, but this drug is not used commonly in the United States. Digitoxin is used in Europe. DTLIS may similarly affect measurement of serum digitoxin concentrations in elderly people. However, DLIS concentrations in elderly people have been studied inadequately in the past, and DTLIS levels in elderly people have not been studied. Yamamoto et al 13 studied DLIS concentrations in elderly patients not receiving digoxin. They reported a range of DLIS concentrations from 0.00 to 0.74 ng/ml ( nmol/l) in patients older than 65 years and concluded that DLIS concentrations were significantly higher in patients older than 65 years compared with patients younger than 35 years. 13 In contrast, Lackner et al 14 found no difference in DLIS concentrations between elderly (older than 70 years) and younger (younger than 55 years) people and concluded that serum digoxin concentrations in elderly people were not affected by DLIS. The present study was designed to resolve this conflict. We studied older and younger groups of patients with and without liver disease or uremia. Our hypothesis is that elevated an DLIS concentration is associated with volume expansion and not with age. Materials and Methods Digoxin and digitoxin were purchased from Sigma Chemical (St Louis, MO). High-performance liquid chromatography (HPLC) grade methanol was obtained from Aldrich Chemical (Milwaukee, WI). Standard solutions of digoxin and digitoxin were prepared in HPLC-grade methanol. FPIA kits for measuring digoxin and digitoxin concentrations were purchased from Abbott Laboratories (Abbott Park, IL), and the assays were run using a TDx/FLX analyzer (Abbott Laboratories). The microparticle enzyme immunoassay (MEIA) kits for digoxin also were obtained from the Abbott Laboratories, but the assays were run using an AxSYM analyzer (Abbott Laboratories). Centrifree Micropartition System for ultrafiltration was obtained from Amicon (Danvers, MA). DLIS or serum digoxin concentrations were measured by both FPIA and MEIA. The FPIA for digoxin requires a serum pretreatment step: 200 µl of serum was treated with 200 µl of a precipitating agent containing 5-sulfosalicylic acid in 50% methanol. After mixing, the specimen was centrifuged at a high speed to separate precipitated protein from the supernatant. The clear supernatant was assayed for digoxin. The assay was linear up to a serum digoxin concentration of 5.0 ng/ml (6.4 nmol/l), and the sensitivity of the assay was 0.2 ng/ml (0.3 nmol/l). The MEIA for digoxin does not require serum pretreatment. The assay was linear up to a serum digoxin concentration of 4.0 ng/ml (5.1 nmol/l). The sensitivity of the assay was 0.3 ng/ml (0.4 nmol/l). DTLIS and digitoxin concentrations were measured by the FPIA for digitoxin. The FPIA for digitoxin requires pretreatment. In this step, 300 µl of methanol was added to 100 µl of serum to precipitate proteins. Clear supernatant after centrifugation was used for digitoxin measurement. The assay was linear up to a serum digitoxin concentration of 80 ng/ml (104.8 nmol/l), and the sensitivity of the assay was 2.0 ng/ml (2.6 nmol/l). We measured free digoxin concentrations in protein-free ultrafiltrate prepared by centrifuging serum with a Centrifree Micropartition Ultrafiltrate device for 40 minutes at 1500g. Then 200 µl of protein-free ultrafiltrate was treated with 200 µl of protein precipitating agent. As expected, no protein precipitation was observed. After mixing, the specimen was assayed for digoxin. Serum albumin, creatinine, serum urea nitrogen, and bilirubin concentrations were measured using a Hitachi 747 analyzer and reagent systems supplied by the manufacturer (Boehringer Mannheim, Indianapolis, IN). The manufacturer s recommended protocols were used. Statistical analyses were performed using an independent 2-tailed t test. We considered a difference significant only at a 95% confidence interval (P <.05). We also performed regression analysis to see the correlation between serum digoxin concentrations measured by the MEIA and FPIA in patients receiving digoxin. Results We studied serum samples from 30 people older than 65 years and 25 people younger than 50 years for possible DLIS and DTLIS activities. These subjects had no conditions that might lead to volume expansion. We observed no measurable DTLIS activity in any subject. We also observed no DLIS activity in any subject younger than 50 years and in only 1 subject older than 65 years. This 70-year-old subject showed a measurable DLIS concentration of 0.2 ng/ml (0.3 nmol/l) digoxin equivalent. This value is at the detection limit of the FPIA (detection limit 0.3 nmol/l). Therefore, we consider this DLIS concentration very low. American Society of Clinical Pathologists Am J Clin Pathol 2001;115:
3 Wu et al / DIGOXIN-LIKE AND DIGITOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN ELDERLY PEOPLE We also studied digoxin concentrations in 14 patients older than 65 years and 8 patients younger than 50 years who were receiving digoxin. These patients had normal creatinine and bilirubin concentrations. We observed excellent agreement between serum digoxin concentrations measured by the MEIA and the FPIA Table 1 in older and younger patients. We observed measurable DLIS and DTLIS concentrations in 11 of 20 subjects with liver disease or uremia who were younger than 50 years. We also observed measurable DLIS and DTLIS concentrations in 9 of 18 subjects who were older than 65 years and had significant liver disease or uremia Table 2. We observed lower serum digoxin concentrations when measured by the MEIA and higher digoxin concentrations when measured by the FPIA in volume-expanded patients receiving digoxin. For example, 1 patient (older than 65 years) receiving digoxin had a total digoxin concentration of 2.9 ng/ml (3.7 nmol/l) when measured by the FPIA and 1.7 ng/ml (2.2 nmol/l) when measured by the MEIA. However, free digoxin concentrations were comparable Table 3. We observed a similar trend in total digoxin concentrations in other volume-expanded subjects who received digoxin. The free fraction of digoxin tended to be elevated in elderly people compared with younger people. The mean free fraction was 78.1% in elderly people and 70.9% in Table 1 Total and Free Digoxin Concentrations in Patients Receiving Digoxin Digoxin Concentration, Total younger people. However, the difference was not statistically significant. Albumin concentrations tended to be lower in elderly people. The mean albumin concentration in elderly people was 3.2 g/dl (32 g/l), while in people younger than 50 years, it was 3.6 g/dl (36 g/l). Again, the difference was not statistically significant. Discussion Our data clearly demonstrated that in elderly people without liver disease or uremia, DLIS and DTLIS are not present in sufficient concentrations to interfere in the serum digoxin assay or the serum digitoxin assay. On the other hand, we observed elevated DLIS and DTLIS concentrations in patients with liver disease or uremia regardless of the age of the patient. Our results resolve the controversy of the association of DLIS with old age. Lackner et al 14 studied patients with normal serum creatinine levels and found no association between DLIS and age. On the other hand, Yamamoto et al 13 reported that higher DLIS concentrations were associated with older age. Some of the elderly patients in the study by Yamamoto et al 13 received drip infusion therapy with a sodium-containing solution, which may have caused volume expansion. The increased DLIS concentrations in these patients may be secondary to volume Patient No. MEIA FPIA Free Free Digoxin, % Albumin, g/dl (g/l) Older than 65 years (1.5) 1.0 (1.3) 0.7 (0.9) (35) (1.7) 1.1 (1.4) 0.9 (1.2) (31) (1.4) 1.2 (1.5) 0.8 (1.0) (39) (1.8) 1.4 (1.8) 1.2 (1.5) (25) (2.8) 2.3 (2.9) 2.0 (2.6) (26) (1.0) 0.8 (1.0) 0.6 (0.8) (32) (2.3) 1.8 (2.3) 1.5 (1.9) (32) (1.4) 1.2 (1.5) 1.1 (1.4) (17) (2.4) 1.9 (2.4) 1.6 (2.0) (29) (0.9) 0.7 (0.9) 0.5 (0.6) (37) (2.6) 1.9 (2.4) 1.6 (2.0) (34) (1.2) 0.9 (1.2) 0.6 (0.8) (38) (0.9) 0.7 (0.9) 0.5 (0.6) (36) (1.2) 0.8 (1.0) 0.6 (0.8) (35) Younger than 50 years (0.8) 0.5 (0.6) 0.3 (0.4) (48) (2.4) 2.1 (2.7) 1.6 (2.0) (32) (0.8) 0.5 (0.6) 0.3 (0.4) (41) (1.2) 0.9 (1.2) 0.7 (0.9) (31) (8.8) 6.5 (8.3) 4.9 (6.2) (34) (0.6) 0.5 (0.6) 0.4 (0.5) (28) (0.9) 0.7 (0.9) 0.5 (0.6) (38) (0.4) 0.3 (0.4) 0.2 (0.3) (37) FPIA, fluorescence polarization immunoassay; MEIA, microparticle enzyme immunoassay. 602 Am J Clin Pathol 2001;115: American Society of Clinical Pathologists
4 Clinical Chemistry / ORIGINAL ARTICLE Table 2 Concentrations of Digoxin-Like and Digitoxin-Like Immunoreactive Substances in Patients With Liver Disease or Uremia Digoxin Equivalent, Digitoxin Equivalent, Patient No. MEIA FPIA FPIA Older than 65 years 1 ND ND 4.7 (6.2) 2 ND 0.2 (0.3) 2.0 (2.6) 3 ND 2.0 (2.6) 9.3 (12.2) 4 ND 0.5 (0.7) 4.1 (5.4) 5 ND 0.9 (1.2) 4.9 (6.4) 6 ND 0.8 (1.0) 6.8 (8.9) 7 ND 0.7 (0.9) 4.3 (5.6) 8 ND 0.7 (0.9) ND 9 ND 0.6 (0.8) 4.5 (5.9) Younger than 50 years 1 ND 0.2 (0.3) 2.7 (3.5) 2 ND 0.5 (0.6) 2.3 (3.0) 3 ND ND 6.1 (8.0) 4 ND 0.5 (0.6) 2.5 (3.3) 5 ND 0.3 (0.4) 2.9 (3.8) 6 ND 0.7 (0.9) 3.3 (4.3) 7 ND 0.6 (0.8) ND 8 ND 0.5 (0.6) 4.0 (5.2) (0.5) 0.5 (0.6) ND 10 ND 0.4 (0.5) 3.9 (5.1) 11 ND 0.6 (0.8) ND FPIA, fluorescence polarization immunoassay; MEIA, microparticle enzyme immunoassay; ND, not done. Table 3 Total and Free Digoxin Concentrations in Patients With Liver Disease and Receiving Digoxin Total Digoxin, Free Digoxin, Age Group, y/ Patient MEIA FPIA MEIA FPIA Younger than 50 A 0.8 (1.0) 1.0 (1.3) 0.8 (1.0) 0.8 (1.0) B 2.8 (3.6) 4.1 (5.2) 2.6 (3.3) 2.5 (3.2) Older than 65 C 1.7 (2.2) 2.9 (3.7) 2.0 (2.6) 2.0 (2.6) D 1.1 (1.4) 1.5 (1.9) 1.0 (1.3) 1.2 (1.5) E 1.2 (1.5) 1.6 (2.0) 1.1 (1.4) 1.1 (1.4) FPIA, fluorescence polarization immunoassay; MEIA, microparticle enzyme immunoassay. expansion. Our study clearly demonstrated that there is no association between elevated DLIS concentrations and old age. We also demonstrated that elderly people did not have elevated DTLIS concentrations. DTLIS concentrations in elderly people have not been studied previously. Good correlation between serum digoxin concentrations measured by both the MEIA and FPIA for digoxin further indicated that measurement of the serum digoxin concentration in elderly patients receiving digoxin was not affected by DLIS. In the presence of DLIS, there is poor agreement between the digoxin concentrations measured by the MEIA and the FPIA. Usually, the digoxin concentrations measured by the FPIA are falsely elevated. The values are falsely lowered when measured by the MEIA owing to negative interference of DLIS. 10 We showed this poor correlation between serum digoxin concentration in 5 patients with liver disease who also were receiving digoxin. One patient was younger than 50 years, while another patient was older than 65 years (Table 3). Elderly people who have normal creatinine and bilirubin concentrations do not have sufficient concentrations of DLIS or DTLIS to interfere with measurement of the concentration of serum digoxin or digitoxin. However, if an elderly patient has substantial liver disease, uremia, or other pathologic condition that may lead to volume expansion, elevated DLIS concentrations may be present in the serum, and free digoxin should be monitored instead of total digoxin to eliminate such interference. However, we studied a small group of patients. A more detailed study with a larger patient population is needed to confirm our preliminary observations. From the Department of Pathology and Laboratory Medicine, University of Texas Houston Medical School. Address reprint requests to Dr Dasgupta: Dept of Pathology and Laboratory Medicine, University of Texas Houston Medical School, 6431 Fannin, MSB 2.292, Houston, TX References 1. Nanji AA, Greenway DC. Falsely raised plasma digoxin concentrations in liver disease. Br Med J (Clin Res Ed). 1985;290: Soldin SJ. Digoxin issues and controversies. Clin Chem. 1986;32: Graves SW, Brown B, Valdes R Jr. Digoxin-like immunoreactive substances in a patient with renal impairment. Ann Intern Med. 1983;99: Sault MH, Vasdev SC, Longerich LL. Endogenous digoxinlike substances in patients with combined hepatic and renal failure. Ann Intern Med. 1984;58: Cloix JF. Endogenous digitalis-like compounds. Hypertension. 1987;10(suppl I): Shilo L, Adawi A, Solomon G, et al. Endogenous digoxin-like immunoreactivity in congestive heart failure. Br Med J (Clin Res Ed). 1987;295: Valdes R Jr, Graves SW. Protein binding of endogenous digoxin-immunoactive factors in human serum and its variation with clinical condition. J Clin Endocrinol Metab. 1985;60: Stone JA, Soldin SJ. An update on digoxin. Clin Chem. 1989;35: Jortani S, Miller JJ, Helm RA, et al. Unexpected suppression of digoxin values caused by DLIS [abstract]. Clin Chem. 1996;42:S124. American Society of Clinical Pathologists Am J Clin Pathol 2001;115:
5 Wu et al / DIGOXIN-LIKE AND DIGITOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN ELDERLY PEOPLE 10. Dasgupta A, Trejo O. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay: elimination of interference by monitoring free digoxin concentrations. Am J Clin Pathol. 1999;111: Luke M, Dasgupta A. Digitoxinlike and digoxinlike immunoreactivities in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities. Ther Drug Monit. 1997;19: Ebara H, Suzuki S, Nagashima K, et al. Digoxin and digitoxin-like immunoreactive substances in amniotic fluid, cord blood and serum of neonates. Pediatr Res. 1986;20: Yamamoto T, Takano K, Sanaka M, et al. Digoxin-like immunoreactive substances in elderly patients and its impact on the TDx digoxin assay. Ther Drug Monit. 1998;20: Lackner TE, Lau BW, Parvin C, et al. Endogenous digoxinlike immunoreactivity in elderly patients with normal serum creatinine concentrations. Clin Pharm. 1988;7: Am J Clin Pathol 2001;115: American Society of Clinical Pathologists
Amitava Dasgupta, PhD, 1 David A. Biddle, MD, 1 Alice Wells, MT(ASCP), 1 and Pradip Datta, PhD 2. Abstract
Clinical Chemistry / INTERFERENCE F CHAN SU INDIGXIN IMMUNASSAYS Positive and Negative Interference of the Chinese Medicine Chan Su in Serum Digoxin Measurement Elimination of Interference by Using a Monoclonal
More informationAmitava Dasgupta, PhD, and Meredith A. Reyes, MD. Abstract
Clinical Chemistry / GINSENG AND DIGOXIN IMMUNOASSAYS Effect of Brazilian, Indian, Siberian, Asian, and North American Ginseng on Serum Digoxin Measurement by Immunoassays and Binding of Digoxin-like Immunoreactive
More informationAmitava Dasgupta, PhD, and Kathleen A. Szelei-Stevens, MD. Abstract
Clinical Chemistry / DAN SHEN, LU-SHEN-WAN, AND DIGIBIND Neutralization of Free Digoxin-like Immunoreactive Components of Oriental Medicines Dan Shen and Lu-Shen-Wan by the Fab Fragment of Antidigoxin
More informationRapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing
Clinical Chemistry / SPOT TESTS TO DETECT ADULTERANTS IN URINE SPECIMENS Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing Amitava Dasgupta, PhD,
More informationInterference between eplerenone and digoxin in an enzyme multiplied immunoassay technique and chemiluminescent immunoassay
Original Article Interference between eplerenone and digoxin in an enzyme multiplied immunoassay technique and chemiluminescent immunoassay Tomoyuki Yamada* 1, Kaoru Suzuki 1, Kazuhito Ueda, Ken Iguchi,
More informationEndogenous and Exogenous Digoxin-like Immunoreactive Substances Impact on Therapeutic Drug Monitoring of Digoxin
Clinical Chemistry / DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES AND DIGOXIN MEASUREMENT Endogenous and Exogenous Digoxin-like Immunoreactive Substances Impact on Therapeutic Drug Monitoring of Digoxin Amitava
More informationA Theoretical Method for Normalizing Total Serum Valproic Acid Concentration in Hypoalbuminemic Patients
J Pharmacol Sci 97, 489 493 (2005) Journal of Pharmacological Sciences 2005 The Japanese Pharmacological Society Full Paper A Theoretical Method for Normalizing Total Serum Valproic Acid Concentration
More informationHexagon PSA. Design Verification. Contents
Design Verification Hexagon PSA Contents 1. Function...2 2. Sensitivity, Dynamic Range and Traceability...2 Description of Control Materials...2 Analytical Sensitivity...2 3. Clinical Evaluation...3 Evaluation
More informationClinical Chemistry
Western Technical College 10513155 Clinical Chemistry Course Outcome Summary Course Information Description Career Cluster Instructional Level Total Credits 5.00 Introduces Clinical Chemistry techniques
More informationStandard Operating Procedure
Subject Free Thyroxine (FT4-II) cobas e411 Index Number Lab-1594 Section Regional/Affiliate Subsection Laboratory Category Departmental Contact Goplin, Darcy Last Revised 2/2/2017 References Required document
More informationLaboratory and Measurement Issues. Greg Miller, PhD Virginia Commonwealth University Richmond, VA
Laboratory and Measurement Issues Greg Miller, PhD Virginia Commonwealth University Richmond, VA Outline Serum/plasma creatinine Serum/plasma cystatin C Urine albumin Urine protein Creatinine standardization
More informationShyamali Pal. Page 315 ejifcc2017vol28no4pp R B Diagnostic Private Limited
Evaluation of the correlation coefficient of polyethylene glycol treated and direct prolactin results and comparability with different assay system results Shyamali Pal R B Diagnostic Private Limited INFO
More informationImmunoassay of Estradiol: Unanticipated Suppression by Unconjugated Estriol
Clinical Chemistry 50:1 160 165 (2004) Endocrinology and Metabolism Immunoassay of Estradiol: Unanticipated Suppression by Unconjugated Estriol Zhimin (Tim) Cao, 1* Thomas A. Swift, 2 Clint A. West, 1
More information25 OH Vitamin D Rapid Test
INSTRUCTION FOR USE REF:GDB 7120-25T 25 OH Vitamin D Rapid Test A Rapid Sandwich Immunochromatographic Test for Quantitative Detection of total 25-OH Vitamin D in human finger-prick blood For In Vitro
More informationConference. Clinical Chemistry 43: (1997) Oak Ridge
Clinical Chemistry 43:9 1744 1748 (1997) Oak Ridge Conference In vitro effects of a novel hemoglobin-based oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank
More informationSelected Clinical Calculations Chapter 10. Heparin-Dosing calculations
Selected Clinical Calculations Chapter 10 Heparin-Dosing calculations Heparin is a heterogeneous group of muco-polysaccharides that have anticoagulant properties (slows clotting time). Heparin salt, as
More informationAnalysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ
Application Note Clinical Research Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ Authors Jennifer Hitchcock 1, Lauren Frick 2, Peter Stone 1, and Vaughn Miller 2 1 Agilent
More informationCurrent Issues of Therapeutic Drug Monitoring (TDM) in Children in Hong Kong
Current Issues of Therapeutic Drug Monitoring (TDM) in Children in Hong Kong Dr Albert Chan, MD Consultant Chemical Pathologist, PMH Director, HA Toxicology Reference Lab HATS Conference 5 Mar 2011 Dinner
More informationMeasurement of Digoxin by Radioimmunoassay
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 7, No. 1 Copyright 1977, Institute for Clinical Science Measurement of Digoxin by Radioimmunoassay PHILIP R. WALSH, Ph.D.,* J. FREDERICK CRAWFORD, Ph.D.,*
More informationKinetic assay of serum and urine for urea with use of urease and leucine dehydrogenase
Clinical Chemistry 43:10 1932 1936 (1997) Automation and Analytical Techniques Kinetic assay of serum and urine for urea with use of urease and leucine dehydrogenase Yoshitaka Morishita, 1 * Kiyoshi Nakane,
More informationMonitoring of Blood Cyclosporine Concentration in Steroid-Resistant Nephrotic Syndrome
ORIGINAL ARTICLE Monitoring of Blood Cyclosporine Concentration in Steroid-Resistant Nephrotic Syndrome Masayo Naito, Takashi Takei, Aya Eguchi, Keiko Uchida, Ken Tsuchiya and Kosaku Nitta Abstract Objective
More informationOpiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided
Opiates Rapid Test Cat. No.:DTS137 Pkg.Size:50T Intended use The CD One Step Opiates Screening Test is a rapid, qualitative immunoassay for the detection of opiates and opiate metabolites in urine. The
More informationQuantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System
Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System Marta Kozak Clinical Research Applications Group Thermo Fisher Scientific San Jose CA Clinical Research use only, Not for
More informationPHARMACEUTICAL INFORMATION AZILSARTAN
AZEARLY Tablets Each Tablet Contains Azilsartan 20/40/80 mg PHARMACEUTICAL INFORMATION AZILSARTAN Generic name: Azilsartan Chemical name: 2-Ethoxy-1-{[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-
More informationDetermination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples
Determination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples Application Note Forensic Toxicology Authors Joe Crifasi Saint Louis University Forensic Toxicology Laboratory Saint Louis, MO, USA Ron
More informationPerformance Characteristics of Eight Estradiol Immunoassays
Clinical Chemistry / EVALUATION OF EIGHT ESTRADIOL IMMUNOASSAYS Performance Characteristics of Eight Estradiol Immunoassays David T. Yang, MD, 1 William E. Owen, MT(ASCP), 2 Carol S. Ramsay, 3 Hui Xie,
More informationReferences Required document for Laboratory Accreditation by the College of American Pathologists.
Subject NT-proBNP Cobas e601 Index Number Lab-4011 Section Laboratory Subsection Chemistry Category Departmental Contact Benjamin Michel Last Revised 10/19/2016 References Required document for Laboratory
More informationNovel Spot Tests for Detecting the Presence of Zinc Sulfate in Urine, a Newly Introduced Urinary Adulterant to Invalidate Drugs of Abuse Testing
Novel Spot Tests for Detecting the Presence of Zinc Sulfate in Urine, a Newly Introduced Urinary Adulterant to Invalidate Drugs of Abuse Testing Kerry J. Welsh, MD, PhD, Jennifer E. Dierksen, MD, Jeffrey
More informationThe NGAL Turbidimetric Immunoassay Reagent Kit
Antibody and Immunoassay Services Li Ka Shing Faculty of Medicine, University of Hong Kong The NGAL Turbidimetric Immunoassay Reagent Kit Catalogue number: 51300 For the quantitative determination of NGAL
More informationTDM. Measurement techniques used to determine cyclosporine level include:
TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.
More informationReference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay
Original Article Annals of Clinical Biochemistry 2015, Vol. 52(1) 61 66! The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: 10.1177/0004563214547779 acb.sagepub.com
More informationHandbook of Drug Monitoring Methods
Handbook of Drug Monitoring Methods Handbook of Drug Monitoring Methods Therapeutics and Drugs of Abuse Edited by Amitava Dasgupta, phd,dabcc,facb Department of Pathology and Laboratory Medicine University
More informationDIRECT ENZYMATIC HbA1c ASSAY
DIRECT ENZYMATIC HbA1c ASSAY ACCURATE AND SIMPLE DIAZYME INNOVATIONS IN CLINICAL DIAGNOSTICS About Diazyme Diazyme Laboratories is a Division of General Atomics located in Poway, California. Diazyme uses
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29755 holds various files of this Leiden University dissertation. Author: Moes, Dirk Jan Alie Roelof Title: Optimizing immunosuppression with mtor inhibitors
More informationThe Adiponectin Turbidimetric Immunoassay Reagent Kit
The Adiponectin Turbidimetric Immunoassay Reagent Kit Catalogue number: 51010 For the quantitative determination of Adiponectin in human serum and plasma This package insert must be read in its entirety
More informationINSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY
INTENDED USE INSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY INSTANT-VIEW H. pylori Rapid Test is a rapid qualitative immunoassay
More informationSCIEX Vitamin D 200M Assay for the Topaz System
The First FDA-Cleared LC-MS/MS Assay for Vitamin D SCIEX Vitamin D 200M Assay for the Topaz System The first FDA-cleared LC-MS/MS assay for Vitamin D Vitamin D is an important building block for human
More informationSeeing is not Believing (13-Nov-2004)
In: 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) & 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP (Eds.) Publisher: American
More informationOriginal Article Interfering effect of bilirubin on the determination of alkaline phosphatase
Int J Clin Exp Med 2014;7(11):4244-4248 www.ijcem.com /ISSN:1940-5901/IJCEM0002083 Original Article Interfering effect of bilirubin on the determination of alkaline phosphatase Zhong Wang, Hongyan Guo,
More informationHexagon OBTI. Design Verification. Contents
Design Verification Hexagon OBTI Contents 1 Function... 2 2 Analytical sensitivity... 2 2.1 Description of control materials... 2 2.2 Results with human haemoglobin... 2 3 Specificity, cross-reactivity
More informationAudit of a monitoring service for free phenytoin
Br. J. clin. Pharmac. (1985), 19, 693-697 Audit of a monitoring service for free phenytoin G. M. PETERSON, S. McLEAN, 2R. J. von WITT & 'K. S. MILLINGEN School of Pharmacy and 'Department of Medicine,
More informationUSING THE ACCESS AMH ASSAY IN YOUR LABORATORY
INFORMATION BULLETIN USING THE ACCESS AMH ASSAY IN YOUR LABORATORY ///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
More informationImproving the Accuracy of Hemoglobin A 1c. : Your Help Is Needed
Improving the Accuracy of Hemoglobin A 1c : Your Help Is Needed Kristina Jackson Behan, PhD, MT(ASCP) (Clinical Laboratory Sciences Program, University of West Florida, Pensacola, FL) DOI: 10.1309/RTVTWPYPTPA5YAGU
More informationDisopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases
Br. J. clin. Pharmac. (1987), 24, 199-26 Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases H. ECHIZEN', S. SAIMA2 & T. ISHIZAKI'
More informationSee external label 96 tests ULTRASENSITIVE THYROID STIMULATING HORMONE (u-tsh) TSH Ultra Sensitive
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationSupplementary material: Materials and suppliers
Supplementary material: Materials and suppliers Electrophoresis consumables including tris-glycine, acrylamide, SDS buffer and Coomassie Brilliant Blue G-2 dye (CBB) were purchased from Ameresco (Solon,
More informationCME/SAM. An Examination of the Usefulness of Repeat Testing Practices in a Large Hospital Clinical Chemistry Laboratory
Clinical Chemistry / Repeat Testing Practices in Clinical Chemistry An Examination of the Usefulness of Repeat Testing Practices in a Large Hospital Clinical Chemistry Laboratory Carl O. Deetz, MD, PhD,
More informationDelta Check Calculation Guide
Delta Check Calculation Guide National Technology 2017, All Rights Reserved By Senior Scientific Researcher, Asmaa Taher Table of Contents Definition... 2 Purpose... 2 Delta Check Research Studies... 2
More information1 Introduction Imprecision Within-run imprecision, results Day-to-day imprecision, results... 2
Design Verification liquicolor 1 Introduction... 2 2 Imprecision... 2 2.1 Within-run imprecision, results... 2 2.2 Day-to-day imprecision, results... 2 3 Linearity and Detection Limit... 2 3.1 Linearity...
More informationThe analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS
The analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS Brett McWhinney, Supervising Scientist, HPLC Section, Pathology Central, Pathology Queensland Overview 1. Overview of Pathology
More informationA Percent Correction Formula for Evaluation of Mixing Studies
Coagulation and Transfusion Medicine / A PERCENT CORRECTION FORMULA FOR EVALUATION OF MIXING STUDIES A Percent Correction Formula for Evaluation of Mixing Studies Sheng-hsiung Chang, MD, Veronica Tillema,
More informationUltrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System
Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System Application Note Forensic Toxicology Authors Nikunj R. Parikh, Michelle
More informationDiagnostic reagent for quantitative in vitro determination of Urea / Blood Urea Nitrogen in serum, plasma and urine by colorimetry.
2013/07/30 A93A01315AUS A11A01641 60 ml 15 ml Pentra C400 Diagnostic reagent for quantitative in vitro determination of Urea / Blood Urea Nitrogen in serum, plasma and urine by colorimetry. QUAL-QA-TEMP-0846
More informationDetermination of Bath Salts (Pyrovalerone Analogs) in Biological Samples
Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples Application Note Forensic Toxicology Authors Joe Crifasi Saint Louis University Forensic Toxicology Laboratory Saint Louis, Mo.
More informationEstablishment of Reference Intervals for Thyroid- Stimulating Hormone and Free Thyroxine in Amniotic Fluid Using the Bayer ADVIA Centaur
Clinical Chemistry / THYROID HORMONES IN AMNIOTIC FLUID Establishment of Reference Intervals for Thyroid- Stimulating Hormone and Free Thyroxine in Amniotic Fluid Using the Bayer ADVIA Centaur Nikola A.
More informationA prospective study of the clarithromycin digoxin interaction in elderly patients
Journal of Antimicrobial Chemotherapy (2002) 50, 601 606 DOI: 10.1093/jac/dkf176 A prospective study of the clarithromycin digoxin interaction in elderly patients P. Zapater 1 *, S. Reus 2, A. Tello 2,
More informationValidation of a Reliable LC-MS/MS Method for Analysis of Simultaneously in Clinical Laboratory
Validation of a Reliable LC-MS/MS Method for Analysis of Simultaneously in Clinical Laboratory Five Steroids Atecla Nunciata Lopes Alves, Berenice Bilharinho Mendonca, Helena Panteliou Lima Valassi. Laboratório
More informationSubstance abuse is a significant problem in the United
Interpretation and Utility of Drug of Abuse Immunoassays Lessons From Laboratory Drug Testing Surveys Stacy E. F. Melanson, MD, PhD; Leland Baskin, MD; Barbarajean Magnani, PhD, MD; Tai C. Kwong, PhD;
More information25-Hydroxy Vitamin D TOTAL (25HD) on Liaison XL
25-Hydroxy Vitamin D TOTAL (25HD) on Liaison XL I. PRINCIPLE The role of vitamin D in bone and mineral metabolism was recognized from its first identification as a factor that could cure rickets. However,
More informationTherapeutic Drug Monitoring
Therapeutic Drug Monitoring news from the laboratory Pieter Vermeersch, Steven Pauwels, Matthijs Oyaert Laboratory Medicine, UZ Leuven Overview 1. Introduction 2. Analytical methods 3. Testing on dry blood
More informationCaution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard. Product Number: AD0013
TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard Product Number: AD0013 INTRODUCTION: Fluorescent isothiocyanato-activated
More informationPhospholipid Assay Kit
Phospholipid Assay Kit Catalog Number KA1635 100 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General Information...
More informationInfectious Mononucleosis IM Cassette Test RAPU04A830
Infectious Mononucleosis IM Cassette Test RAPU04A830 DIAsource ImmunoAssays S.A. - Rue de l'industrie, 8 - B-1400 Nivelles - Belgium : 090714/1 en DIAsource IM (Mononucleosis) Test Cassette for whole blood,
More informationDiagnostic Testing in Cushing's Syndrome: Reassessment of 17-hydroxycorticosteroid and 17-ketosteroid Measurements
CRTCAL REVEW [ K e i t h D u n c a n, M. D. March, 1985 Diagnostic Testing in Cushing's Syndrome: Reassessment of 17-hydroxycorticosteroid and 17-ketosteroid Measurements ntroduction The measurement of
More informationLANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade
AD0017P-4 (en) 1 LANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade INTRODUCTION Fluorescent isothiocyanato-activated (ITC-activated) Eu-W1024 chelate is optimized for labelling proteins
More informationThe NEPHROCHECK Test System Training Program. The NEPHROCHECK Training Program US: Astute Medical, Inc PN Rev D 2014/09/16
The NEPHROCHECK Test System Training Program The NEPHROCHECK Training Program US: Astute Medical, Inc. 2014 PN 700001 Rev D 2014/09/16 Learning Objectives At the conclusion of this training, participants
More informationretardation in infants. A wide variety of analytical methods for the analysis of
IN THE NAME OF GOD Diagnosis and measurment of Phenylalanine in plasma and dried bilood spot (DBS) by a simple and sensitive HPLC method and compaire with Recipe Reference Health Laboratory Research Center,
More information25 OH Vitamin D Rapid test
INSTRUCTION FOR USE REF:GDB 7120-25T 25 OH Vitamin D Rapid test Rapid Whole Blood Vitamin D Test A Rapid Sandwich Immunochromatographic Test for the Quantitative Detection of total 25-OH Vitamin D in human
More informationazilsartan medoxomil
azilsartan medoxomil edarbi 40mg Tablet 80mg Tablet ANTIHYPERTENSIVE Angiotensin II Receptor Antagonist FORMULATION: Each tablet contains 40mg Azilsartan medoxomil (as potassium) Each tablet contains 80mg
More informationPancreatic Insulinoma Presenting. with Episodes of Hypoinsulinemic. Hypoglycemia in Elderly ---- A Case Report
2008 19 432-436 Pancreatic Insulinoma Presenting with Episodes of Hypoinsulinemic Hypoglycemia in Elderly ---- A Case Report Chieh-Hsiang Lu 1, Shih-Che Hua 1, and Chung-Jung Wu 2,3 1 Division of Endocrinology
More informationA Fully Automated Enzyme Immunoassay for the Measurement of Cortisol in Biological Fluids
Bacarese-Hamilton et al.: Automated enzyme immunoassay for cortisol 531 Eur. J. Clin. Chem. Clin. Biochem. Vol. 30, 1992, pp. 531-535 1992 Walter de Gruyter & Co. Berlin New York A Fully Automated Enzyme
More informationUPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research
Stephen Balloch and Gareth Hammond Waters Corporation, Wilmslow, UK APPLICATION BENEFITS Analytical selectivity afforded by mass selective detection Wide linear measuring range Simple, inexpensive sample
More informationSTORE AT 4 o C Version 3
Instruction Manual Advanced Protein Assay Reagent (Cat. # ADV01) ORDERING INFORMATION To order by phone: (303) - 322-2254 To order by Fax: (303) - 322-2257 To order by e-mail: cserve@cytoskeleton.com Technical
More informationTotal Thyroxine ELISA (T4)
Design Verification Total Thyroxine ELISA (T4) Contents 1 Assay Principle... 2 2 Imprecision... 2 Within-run Imprecision... 2 Between run Imprecision... 2 3 Comparison of Methods, Accuracy... 2 4 Linearity...
More informationAuthor. Introduction. Abstract
Simultaneous Measurement of Sirolimus and Tacrolimus Concentrations in Blood by Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry Application Author Gary L.
More informationNGAL, a new markers for acute kidney injury
NGAL, a new markers for acute kidney injury Prof. J. Delanghe, MD, PhD Dept. Clinical Chemistry Ghent University Lecture Feb 8, 2011 Serum creatinine is an inadequate marker for AKI. > 50% of renal
More informationImproving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology
Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology Pongkwan (Nikki) Sitasuwan, Margarita Marinova, and L. Andrew Lee Integrated Micro-Chromatography Systems, LLC
More informationPOLYTECHNIC OF NAMIBIA SCHOOL OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES BIOMEDICAL SCIENCES PROGRAMME
セ @セ @ POLYTECHNIC OF NAMIBIA SCHOOL OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES BIOMEDICAL SCIENCES PROGRAMME QUALIFICATION(S): Bachelor Of Biomedical Sciences QUALIFICATION CODE: 50BBMS
More informationVITROS MicroSlide Assay Summary
ACET Acetaminophen ALB Albumin EDTA 10 9 TDM PV Specialty 5.5 4 PV Isotonic saline or 10 200 μg/ml 66 1323 μmol/l (μmol/l = μg/ml x 6.616) 1.00 6.00 g/dl 10.0-60.0 g/l (g/l = g/dl x 10) Therapeutic: 670
More informationAnalysis of Hemoglobin A1c from Dried Blood Spot Samples with the Tina-quant II Immunoturbidimetric Method
Journal of Diabetes Science and Technology Volume 4, Issue 2, March 2010 Diabetes Technology Society SYMPOSIUM Analysis of Hemoglobin A1c from Dried Blood Spot Samples with the Tina-quant II Immunoturbidimetric
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT DigiFab, 40 mg/vial digoxin immune Fab, Powder for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each glass vial
More informationPolicy # MI/SER/02/v03 Page 1 of 9 Policy & Procedure Manual
Policy # MI/SER/02/v03 Page 1 of 9 Section: Subject Title: AxSYM System Issued by: LABORATORY MANAGER Original Date: March 14, 2001 Approved by: Laboratory Director Revision Date: October 28, 2003 AXSYM
More informationDRUG-CONJUGATES The drug buprenorphine is conjugated to protein and immobilized as a line on a membrane at the BUP location labeled on the device.
MEDTOX BUPRENORPHINE MEDTOX Buprenorphine is a rapid qualitative screening test for buprenorphine and its metabolites in human urine. 1. INTENDED USE The MEDTOX Buprenorphine Test uses immunochromatographic
More informationDate... Name... Group... Urine sample (Tube No 2)
Date... Name... Group... Instructions for the practical lesson on biochemistry Topic: Non-protein nitrogen compounds Task 1: Estimation of creatinine in serum and urine 1. Trichloroacetic acid 1.22 mol/l
More informationCortisol Assays. The Good, The Bad and The Indifferent. David Ducroq. Cardiff and Vale ulhb WEQAS. Unit 6, Parc Tŷ Glas. Llanishen.
Cortisol Assays The Good, The Bad and The Indifferent David Ducroq Cardiff and Vale ulhb WEQAS Unit 6, Parc Tŷ Glas Llanishen Cardiff www.weqas.com Summary Brief overview of current methods and challenges
More informationThe study of phospholipids in single cells using an integrated microfluidic device
Supporting Information: The study of phospholipids in single cells using an integrated microfluidic device combined with matrix-assisted laser desorption/ionization mass spectrometry Weiyi Xie,, Dan Gao,
More information510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE A. 510(k) Number: k103542 B. Purpose for Submission: Alternative blood glucose test strips for use with LifeScan OneTouch
More informationDetermination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography
Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography Application ote Food Safety Authors Chen-Hao Zhai and Yun Zou Agilent Technologies Co. Ltd.
More informationfor therapeutic drug monitoring
Thermo Scientific TDM Assays for Therapeutic Drug Monitoring Complete solutions for therapeutic drug monitoring TDM tests provide quantitative results to ensure beneficial therapeutic effects by determining
More informationSupporting Information. Prolonged exposure to bisphenol A from single dermal contact events
Supporting Information Prolonged exposure to bisphenol A from single dermal contact events Jiaying Liu, Jonathan W. Martin Table of Contents Table S1. Table S2. Figure S1. Figure S2. Figure S3. Figure
More informationNIH Public Access Author Manuscript Transplant Proc. Author manuscript; available in PMC 2011 April 6.
NIH Public Access Author Manuscript Published in final edited form as: Transplant Proc. 1991 December ; 23(6): 2777 2779. Pharmacokinetics of Cyclosporine and Nephrotoxicity in Orthotopic Liver Transplant
More informationFructose Assay Kit. Catalog Number KA assays Version: 02. Intended for research use only.
Fructose Assay Kit Catalog Number KA1668 100 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General Information...
More informationDesign Verification Function... 2 Analytical sensitivity... 2 Specificity, cross-reactivity and interferences... 3
Design Verification 1 Function... 2 2 Analytical sensitivity... 2 2.1 Description of control materials... 2 2.2 Results with human haemoglobin... 2 3 Specificity, cross-reactivity and interferences...
More informationCholesterol determination using protein-templated fluorescent gold nanocluster probes
Electronic Supplementary Information for Cholesterol determination using protein-templated fluorescent gold nanocluster probes Xi Chen and Gary A. Baker* Department of Chemistry, University of Missouri-Columbia,
More informationCreatinine Test Code: CRE
Creatinine Test Code: CRE Intended Use For in vitro diagnostic use only CARESIDE cartridges are used with the CARESIDE Analyzer to quantitatively measure creatinine concentration in anti-coagulated whole
More informationREAD HIGHLIGHTED CHANGES
BIO-FLASH Toxo IgM 3000-8554 50 tests The BIO-FLASH Toxo IgM is a fully automated chemiluminescent two-step immunoassay for qualitative measurement of IgM antibodies to Toxoplasma gondii in human serum
More informationCONTENTS. STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1
CONTENTS STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1 ELISA protocol for mite (Dermatophagoides spp.) Group 2 ALLERGENS RESULTS (SUMMARY) TABLE
More informationComparison of Modified Jaffe s Kinetic Method and Enzymatic Method of Serum Creatinine Estimation for Precision, Linearity and Effect of Interferent
ORIGINAL ARTICLE Comparison of Modified Jaffe s Kinetic Method and Enzymatic Method Comparison of Modified Jaffe s Kinetic Method and Enzymatic Method of Serum Creatinine Estimation for Precision, Linearity
More informationUltra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification
22 SEPARATION SCIENCE REDEFINED MAY 2005 Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification In the drug discovery process the detection and
More information2. Experimental. Glipizide (>98% purity) and tolbutamide as the internal
266 z.j. Lin et al. / Journal of Chromatography B, 801 (2004) 265-272 (CE) [8]. Extensive reviews on these methodologies including advantages and disadvantages of each methods can be found in the literature
More information